293b cpd has been researched along with ranolazine in 1 studies
| Studies (293b cpd) | Trials (293b cpd) | Recent Studies (post-2010) (293b cpd) | Studies (ranolazine) | Trials (ranolazine) | Recent Studies (post-2010) (ranolazine) |
|---|---|---|---|---|---|
| 100 | 0 | 16 | 799 | 104 | 498 |
| Protein | Taxonomy | 293b cpd (IC50) | ranolazine (IC50) |
|---|---|---|---|
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 6.85 | |
| Voltage-gated sodium channel Nav1.5 cardiac isoform | Canis lupus familiaris (dog) | 6.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belardinelli, L; Shryock, JC; Song, Y; Wu, L | 1 |
1 other study(ies) available for 293b cpd and ranolazine
| Article | Year |
|---|---|
Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes.
Topics: Acetanilides; Action Potentials; Animals; Chromans; Cnidarian Venoms; Delayed Rectifier Potassium Channels; Drug Synergism; Drug Therapy, Combination; Female; Guinea Pigs; Heart Conduction System; Heart Ventricles; Ion Channel Gating; Long QT Syndrome; Male; Myocytes, Cardiac; Piperazines; Piperidines; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Potassium Channels, Voltage-Gated; Pyridines; Ranolazine; Sodium Channels; Sulfonamides; Tetrodotoxin; Time Factors | 2004 |